Ropes & Gray represented Zenas BioPharma in the transaction, and Cooley represented the underwriters. Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company, announced...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here